Consolidated Statements of Cash Flows - USD ($)	4 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (4,251)	$ (1,341,378)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities		(8,326,000)
Loss on initial issuance of Private Placement Warrants		1,716,000
Interest earned on marketable securities held in Trust Account		(14,425)
Transaction costs associated with the Initial Public Offering		788,627
Changes in operating assets and liabilities:
Prepaid expenses		(600,000)
Accrued expenses	4,119	5,772,316
Net cash used in operating activities	(132)	(2,004,860)
Cash Flows from Investing Activities:
Investment of cash into Trust Account		(230,000,000)
Net cash used in investing activities		(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discount paid		225,675,000
Proceeds from sale of Private Placements Warrants		6,600,000
Proceeds from promissory note - related party	155,000	200,000
Repayment of promissory note – related party		(155,000)
Payment of offering costs	(98,295)	(284,639)
Net cash provided by financing activities	56,705	232,035,361
Net Change in Cash	56,573	30,501
Cash – Beginning of period		56,573
Cash – End of period	56,573	87,074
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs	185,880
Offering costs paid by Sponsor in exchange for issuance of founder shares	25,000
Remeasurement adjustment on redeemable common stock		26,003,057
Deferred underwriting fee payable		7,568,750
Initial classification of warrant liability		$ 22,806,000